TOUYUN BIOTECH intends to sell 30% of its shares in V for 5 million yuan.

TOUYUN BIOTECH (01332) announced that on March 6, 2025 (after trading hours), the company's wholly-owned subsidiary APEX CAPITAL BUSINESS LIMITED plans to sell 30% of the shares of Wei Dao International Limited to China Renaissance International Limited for a consideration of RMB 5 million. Upon completion, the group will hold a total of 70% of the target company's shares. It is reported that the target company is primarily engaged in providing QR code and solution services for product packaging, as well as advertising display services.